Abstract:E3 ubiquitin ligases are very important to regulate antiviral immunity during viral infection. Here, we discovered that Ankyrin repeat and SOCS box-containing protein 3 (ASB3), an E3 ligase, are upregulated in the presence of RNA viruses, particularly Influenza A virus (IAV). Notably, overexpression of ASB3 inhibits type I IFN (IFN-I) responses induced by Sendai virus (SeV) and H9N2, and ablation of ASB3 restores SeV and H9N2 infection-mediated transcription of IFN-β and its downstream interferon-stimulated genes (ISGs). Interestingly, animals lacking ASB3 showed a decreased susceptibility to H9N2 and PR8 infections. Mechanistically, ASB3 interacts with MAVS and directly mediates K48-linked polyubiquitination and degradation of MAVS at K297, thereby inhibiting the phosphorylation levels of TBK1 and IRF3, downregulating downstream antiviral signaling. These findings establish ASB3 as a critical negative regulator in controlling the activation of antiviral signaling and describe a novel function of ASB3 that has not been previously reported. IMPORTANCE IAV is a significant zoonotic pathogen that causes infections of the respiratory system. Hosts have evolved multiple strategies to defend against IAV infection. However, not all host proteins play an active defense role. In this study, we found that the E3 ligase ASB3 regulates antiviral immunity by manipulating MAVS stability. Briefly, overexpression of ASB3 degrades MAVS, thereby promoting viral replication. In contrast, ASB3 deletion restores MAVS expression, upregulating IFN-I responses. Additional research revealed that ASB3 mediates the K48-linked polyubiquitination of MAVS at K297, resulting in ASB3 being degraded via the ubiquitin-proteasome pathway. These findings reveal, for the first time, a novel mechanism by which ASB3 negatively regulates antiviral immunity and provides a potential target for anti-IAV drug development.

Lys29-linkage of ASK1 by Skp1−Cullin 1−fbxo21 Ubiquitin Ligase Complex is Required for Antiviral Innate Response

Lck/Hck/Fgr-Mediated Tyrosine Phosphorylation Negatively Regulates TBK1 to Restrain Innate Antiviral Responses.

FBXO6 Regulates the Antiviral Immune Responses Via Mediating Alveolar Macrophages Survival

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1

E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

USP21 Negatively Regulates Antiviral Response by Acting As a RIG-I Deubiquitinase

The deubiquitinase BAP1 and E3 ligase UBE3C sequentially target IRF3 to activate and resolve the antiviral innate immune response

E3 ubiquitin ligases, the powerful modulator of innate antiviral immunity

p38 inhibition provides anti–DNA virus immunity by regulation of USP21 phosphorylation and STING activation

Fine-tuning of antiviral innate immunity by ubiquitination

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Krab-Zinc Finger Protein Znf268a Deficiency Attenuates The Virus-Induced Pro-Inflammatory Response By Preventing Ikk Complex Assembly

TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO

Critical role of Syk-dependent STAT1 activation in innate antiviral immunity

USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA

Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity

PKACs Attenuate Innate Antiviral Response by Phosphorylating VISA and Priming It for MARCH5-mediated Degradation

ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function